Skip to main content
Equibles

WELLS FARGO & COMPANY/MN

Position in MTNB — Matinas BioPharma Holdings, Inc.

CIK 72971 SAN FRANCISCO, CA
Back to MTNB Full portfolio

Position in MTNB

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$62
+$11 QoQ
Shares Held
102
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#15
of 25 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in MTNB Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

WELLS FARGO & COMPANY/MN holds $1,575,562,942 across 417 Biotechnology names. MTNB ranks #393 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 749,528 $372,313,040
2 HALO
Halozyme Therapeutics, Inc.
 1,390,428 $108,828,797
3 ALNY
Alnylam Pharmaceuticals, Inc.
 310,047 $93,333,446
4 REGN
Regeneron Pharmaceuticals, Inc.
 140,802 $87,795,677
5 EXEL
Exelixis, Inc.
 717,840 $39,057,673
6 RVMD
Revolution Medicines, Inc.
 178,780 $33,481,916
7 ARGX
Argenx SE
 34,453 $31,964,458
8 INCY
Incyte Corp
 255,064 $28,914,053

All Filings in MTNB

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $62 102
2026-03-31 $51 102
2025-12-31 $59 102
2025-09-30 $192 102
2025-06-30 $90 102
2025-03-31 $53 102
2024-12-31 $52 102
2024-09-30 $3,901 1,102
2024-06-30 $56,101 355,075
2024-03-31 $28,935 106,774
2023-12-31 $50,057 231,747
2023-09-30 $65,865 506,660
2023-06-30 $203,957 566,550
2023-03-31 $3,090 6,575
2022-12-31 $3,275 6,552
2022-09-30 $13,319 20,942
2022-06-30 $16,436 20,806
2022-03-31 $16,641 20,698
2021-12-31 $20,900 20,694
2021-09-30 $25,590 19,685
2021-06-30 $2,374 3,064
2021-03-31 $19,685 18,748
2020-12-31 $422,282 310,502
2020-09-30 $286,143 373,557
2020-06-30 $437,634 566,152
2020-03-31 $294,897 491,498